C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/09/2004	WO2004106540A1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils)
12/09/2004	WO2004106539A1 Method of screening bacterial growth inhibitor
12/09/2004	WO2004106538A1 Assay for identifying inhibitors of mycobacterium anti-oxidant defense system
12/09/2004	WO2004106537A1 Method of detecting cancerous cell
12/09/2004	WO2004106536A2 Diagnostics and therapeutics for diseases associated with serine protease 8 (prss8)
12/09/2004	WO2004106521A1 Canine cyp1a2 gene polymorphism
12/09/2004	WO2004106520A1 Plant gene activation vector and utilization thereof
12/09/2004	WO2004106517A1 Double-stranded nucleic acid
12/09/2004	WO2004106512A1 Method of enhancing pathogen-resistance of plant
12/09/2004	WO2004106497A2 Imageable animal model of sars infection
12/09/2004	WO2004106495A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004	WO2004106490A2 NOVEL METHODS FOR FINDING MUTATIONS CAUSED BY THE INSERTION OF REPETEAD DNAs
12/09/2004	WO2004106489A2 Nematode GS-like sequences
12/09/2004	WO2004106488A2 Gene expression suppression agents
12/09/2004	WO2004106367A2 Enterococcus antigens
12/09/2004	WO2004105947A2 Localized temperature control for spatial arrays of reaction media
12/09/2004	WO2004105681A2 Cd4+ human papillomavirus (hpv) epitopes
12/09/2004	WO2004105573A2 Method of diagnosis of cancer based on gene expression profiles in cells
12/09/2004	WO2004096021A3 Global analysis of transposable elements as molecular markers of cancer
12/09/2004	WO2004091505A3 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
12/09/2004	WO2004087966A3 Genomic profiling of regulatory factor binding sites
12/09/2004	WO2004087944A8 Improvements in or relating to viability
12/09/2004	WO2004085678A3 Method of preparing dna fragments and applications thereof
12/09/2004	WO2004083462A3 Replication assay for discovering antiviral substances using a high throughput screening (hts) method
12/09/2004	WO2004083368A3 Molecular markers for the baking quality of wheat
12/09/2004	WO2004079326A3 Anaplastic lymphoma kinase assay, reagents and compositions thereof
12/09/2004	WO2004077017A3 Apparatus and method for on-chip concentration using a microfluidic device with an integrated ultrafiltration membrane structure
12/09/2004	WO2004076683A3 Random array dna analysis by hybridization
12/09/2004	WO2004074320A8 Therapeutic targets in cancer
12/09/2004	WO2004069194A9 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
12/09/2004	WO2004068111A3 Methods and compositions for rna detection and quantitation
12/09/2004	WO2004067775A3 Method for the detection of cytosine methylation patterns with high sensitivity
12/09/2004	WO2004067763A3 Genetic diagnosis of alcoholism subtypes
12/09/2004	WO2004066961A3 Use of sendai virus as a human parainfluenza vaccine
12/09/2004	WO2004061123A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
12/09/2004	WO2004061084A8 Modulation of protein functionalities
12/09/2004	WO2004048931A3 Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
12/09/2004	WO2004047759A3 Composition for treating chlamydia infections and method for identifying same
12/09/2004	WO2004047742A3 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
12/09/2004	WO2004047736A3 Modulation of bcl2-associated athanogene expression
12/09/2004	WO2004046369A3 Nucleic acid sequence detection
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2004024893A3 Nell-1 enhanced bone mineralization
12/09/2004	WO2004020981A3 Methods of screening cyclic peptides and identifying targets therefor
12/09/2004	WO2004017728A3 Methods
12/09/2004	WO2004011612A3 Method of detecting and quantifying hepatitis c virus
12/09/2004	WO2004007677A3 In vitro transcription assay for t box antitermination system
12/09/2004	WO2004006866A3 Antifungal therapeutic targets
12/09/2004	WO2003106623A3 Early noninvasive prenatal test for aneuploidies and heritable conditions
12/09/2004	WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/09/2004	WO2003102018A3 Methods for quantitative proteome analysis of glycoproteins
12/09/2004	WO2003101401A3 Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003072114A9 Vascular therapeutics
12/09/2004	WO2003068054A3 Identification of ovarian cancer tumor markers and therapeutic targets
12/09/2004	WO2003062793A3 Analysis device
12/09/2004	WO2003062382A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	WO2003046143A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/09/2004	WO2003043568A3 Compositions and methods for the suppression of mammary epithelial cell proliferation
12/09/2004	WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker
12/09/2004	US20040250317 Cotton event moni5985 and compositions and methods for detection thereof
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040250299 Compound screening method
12/09/2004	US20040249586 Molecular modification assays
12/09/2004	US20040249227 Biosensor and method for detecting analytes by means of time-resolved luminescene
12/09/2004	US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group
12/09/2004	US20040249144 Regulated breast cancer genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249130 Aptamer-toxin molecules and methods for using same
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248976 A DNA fragment probe is used to bind specifically to a target substance; a moisturizer is used to spot the probe to be fixed on a substrate, promote omission, stabilizing the spot shape, increase detection sensitivity of a reaction chip
12/09/2004	US20040248909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairment
12/09/2004	US20040248871 Prevent cell differentiation
12/09/2004	US20040248836 Administering activator of formin homologue overexpression in spleen; adjusting gene expression
12/09/2004	US20040248830 Agents that regulate apoptosis
12/09/2004	US20040248798 Contraceptive methods and compositions related to proteasomal interference
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248775 Methods for screening inhibitors of apoptosis
12/09/2004	US20040248773 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248323 Methods for conducting assays for enzyme activity on protein microarrays
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248286 Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
12/09/2004	US20040248282 Molecular sensing apparatus (biosensors) comprising single macromolecule spanning two electrodes for use in monitoring biopolymer concentrations in fluids
12/09/2004	US20040248275 Forming biomasses of heterogenous planktonic bacteria via exposure to concanavalin a; monitoring efficacy of bactericides/microbiocides; bioremediation and degradation
12/09/2004	US20040248272 Heat-labile desoxyribonuclease I variants
12/09/2004	US20040248271 Using phenol oxidase activity as diagnostic indicator of bacterial infection; diagnosis and prevention of food poisoning
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248236 Bacillus strain and antibiotic screening method
12/09/2004	US20040248235 Apparatus for monitoring hydrogen peroxide plasma sterilization which comprises active enzyme, sterilant-resistant chemical and substrate that is capable of reacting with active enzyme to form enzyme-modified product comprising detectable indicator of sterilization failure
12/09/2004	US20040248234 Sensitive and selective in vitro assay for the detection of reactive drug intermediates

1 ... 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 ... 3003